[go: up one dir, main page]

CU20090206A7 - Solución novedosa no-acuosa tópica de diclofenaco y proceso para su preparación - Google Patents

Solución novedosa no-acuosa tópica de diclofenaco y proceso para su preparación

Info

Publication number
CU20090206A7
CU20090206A7 CU20090206A CU20090206A CU20090206A7 CU 20090206 A7 CU20090206 A7 CU 20090206A7 CU 20090206 A CU20090206 A CU 20090206A CU 20090206 A CU20090206 A CU 20090206A CU 20090206 A7 CU20090206 A7 CU 20090206A7
Authority
CU
Cuba
Prior art keywords
diclofenaco
novedous
preparation
watery solution
solution typical
Prior art date
Application number
CU20090206A
Other languages
English (en)
Other versions
CU23999B1 (es
Inventor
R Patel Ketan
Original Assignee
Troikaa Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Troikaa Pharmaceuticals Ltd filed Critical Troikaa Pharmaceuticals Ltd
Publication of CU20090206A7 publication Critical patent/CU20090206A7/es
Publication of CU23999B1 publication Critical patent/CU23999B1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describe una composición en solución novedosa no-acuosa tópica de sal de diclofenaco farmacéuticamente aceptable. La composición en solución no-acuosa tópica comprende una cantidad terapéuticamente efectiva de sal de diclofenaco farmacéuticamente aceptable, solubilizante, un potenciador de la penetración y solvente, y opcionalmente, un humectante, un revulsivo o irritante local, un potenciador adicional de la penetración y anti-oxidantes, así como su proceso de preparación.
CU2009000206A 2007-06-08 2009-12-04 Solución no-acuosa tópica de diclofenaco y proceso para su preparación CU23999B1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1092MU2007 2007-06-08
PCT/IN2008/000363 WO2009047785A2 (en) 2007-06-08 2008-06-09 A non-aqueous topical solution of diclofenac and process for preparing the same

Publications (2)

Publication Number Publication Date
CU20090206A7 true CU20090206A7 (es) 2011-09-21
CU23999B1 CU23999B1 (es) 2014-06-27

Family

ID=40524886

Family Applications (1)

Application Number Title Priority Date Filing Date
CU2009000206A CU23999B1 (es) 2007-06-08 2009-12-04 Solución no-acuosa tópica de diclofenaco y proceso para su preparación

Country Status (23)

Country Link
US (1) US10702469B2 (es)
EP (1) EP2211837B1 (es)
JP (2) JP5535066B2 (es)
KR (1) KR101517494B1 (es)
CN (1) CN101790370B (es)
AP (1) AP3643A (es)
AU (1) AU2008309170B2 (es)
BR (1) BRPI0811956A8 (es)
CA (1) CA2697458C (es)
CO (1) CO6270203A2 (es)
CU (1) CU23999B1 (es)
DK (1) DK2211837T3 (es)
EA (1) EA018119B1 (es)
ES (1) ES2445443T3 (es)
HK (1) HK1147066A1 (es)
IL (1) IL202009A (es)
MX (1) MX2009013352A (es)
MY (1) MY151437A (es)
PL (1) PL2211837T3 (es)
PT (1) PT2211837E (es)
UA (1) UA97529C2 (es)
WO (1) WO2009047785A2 (es)
ZA (1) ZA200908705B (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100099766A1 (en) * 2008-10-16 2010-04-22 Novartis Ag Topical NSAID compositions having sensate component
EP2416816B1 (en) * 2009-04-10 2014-10-15 Spiracur Inc. Methods and devices for applying closed incision negative pressure wound therapy
US11730709B2 (en) 2010-10-29 2023-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain
US10695431B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US10695432B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US9308213B2 (en) 2010-10-29 2016-04-12 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US8895537B2 (en) 2010-10-29 2014-11-25 Infirst Healthcare Ltd. Compositions and methods for treating cardiovascular diseases
US9737500B2 (en) 2010-10-29 2017-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain
US9744132B2 (en) 2010-10-29 2017-08-29 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US11202831B2 (en) 2010-10-29 2021-12-21 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US9504664B2 (en) 2010-10-29 2016-11-29 Infirst Healthcare Limited Compositions and methods for treating severe pain
US9271950B2 (en) 2010-10-29 2016-03-01 Infirst Healthcare Limited Compositions for treating chronic inflammation and inflammatory diseases
US11224659B2 (en) 2010-10-29 2022-01-18 Infirst Healthcare Limited Solid solution compositions and use in severe pain
ITMI20121205A1 (it) 2012-07-11 2014-01-12 Glycores 2000 Srl Composizione con attivita' antinfiammatoria ed analgesica da somministrare per uso esterno mediante vaporizzazione
JP2014152172A (ja) * 2013-02-08 2014-08-25 Daiya Seiyaku Kk 清涼感付与外用組成物、清涼感付与貼付剤、清涼感付与方法、清涼感付与外用組成物の製造方法、及び、清涼感付与貼付剤の製造方法
BR112015020707B1 (pt) * 2013-02-27 2022-09-13 Laurie Robert Batt Composição transdérmica anidra e método de fabricação da mesma
JP6738120B2 (ja) * 2013-03-29 2020-08-12 小林製薬株式会社 外用医薬組成物
JP6599083B2 (ja) * 2014-03-30 2019-10-30 小林製薬株式会社 外用医薬組成物
JP6580306B2 (ja) * 2014-03-30 2019-09-25 小林製薬株式会社 外用医薬組成物
JP6580305B2 (ja) * 2014-03-30 2019-09-25 小林製薬株式会社 外用医薬組成物
EP3435978A4 (en) * 2016-03-31 2019-12-11 Smartech Topical, Inc. RELEASE SYSTEM
AU2018231842B2 (en) * 2017-03-07 2024-03-21 LYOTROPIC DELIVERY SYSTEMS Ltd Topical delivery systems for active compounds
JP2018030893A (ja) * 2017-11-14 2018-03-01 ダイヤ製薬株式会社 清涼感付与外用組成物の製造方法及び清涼感付与貼付剤の製造方法
CA3155267A1 (en) 2019-11-06 2021-05-14 Thomas Hnat Topical formulations of cyclooxygenase inhibitors and their use
JP2022096997A (ja) * 2020-12-18 2022-06-30 小林製薬株式会社 外用医薬組成物
EP4499036A1 (en) 2022-03-25 2025-02-05 Glycores 2000 srl Topical pharmaceutical composition with anti-inflammatory and analgesic activity and uses thereof

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4353896A (en) 1981-06-08 1982-10-12 Levy Michael A Penetrating topical medicament
US4933184A (en) * 1983-12-22 1990-06-12 American Home Products Corp. (Del) Menthol enhancement of transdermal drug delivery
CA1236029A (en) 1984-05-14 1988-05-03 Edmund Sandborn Pharmaceutical solutions comprising dimethyl sulfoxide
DE3522550A1 (de) 1985-06-24 1987-01-02 Klinge Co Chem Pharm Fab Aufspruehbare pharmazeutische zubereitung fuer die topische anwendung
US5093133A (en) 1990-01-24 1992-03-03 Mcneil-Ppc, Inc. Method for percutaneous delivery of ibuprofen using hydroalcoholic gel
US5318960A (en) * 1992-06-03 1994-06-07 Frank Toppo System for transdermal delivery of pain relieving substances
US5985860A (en) 1992-06-03 1999-11-16 Toppo; Frank System for transdermal delivery of pain relieving substances
US5665378A (en) * 1994-09-30 1997-09-09 Davis; Roosevelt Transdermal therapeutic formulation
US5654337A (en) * 1995-03-24 1997-08-05 II William Scott Snyder Topical formulation for local delivery of a pharmaceutically active agent
US7833543B2 (en) * 1995-06-07 2010-11-16 Durect Corporation High viscosity liquid controlled delivery system and medical or surgical device
US5968542A (en) * 1995-06-07 1999-10-19 Southern Biosystems, Inc. High viscosity liquid controlled delivery system as a device
CN1210463A (zh) 1996-02-07 1999-03-10 株式会社津村 透明双氯芬酸钠的水溶液以及它的药物组合物
DE19725615A1 (de) 1997-06-17 1998-12-24 Permamed Ag Zur topischen Applikation bestimmte Diclofenac-Lösung
US5976566A (en) * 1997-08-29 1999-11-02 Macrochem Corporation Non-steroidal antiinflammtory drug formulations for topical application to the skin
US6193996B1 (en) 1998-04-02 2001-02-27 3M Innovative Properties Company Device for the transdermal delivery of diclofenac
CH693625A5 (it) 1999-02-18 2003-11-28 Inpharma Sa Composizioni farmaceutiche contenenti composti ad attività promotrice di assorbimento di principi attivi.
BRPI0210074B1 (pt) * 2001-05-31 2017-05-30 Hisamitsu Pharmaceutical Co emplastro de anti-inflamatórios não esteroidais percutaneamente absorvível, contendo sais de amônio, promotores de permeação e/ou agentes de solubilização em uma camada de substrato adesivo
US20070196453A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Two or more non-volatile solvent-containing compositions and methods for dermal delivery of drugs
WO2007016766A1 (en) * 2005-08-05 2007-02-15 Nuvo Research Inc. Transdermal drug delivery formulation

Also Published As

Publication number Publication date
AP2010005169A0 (en) 2010-02-28
PL2211837T3 (pl) 2014-05-30
IL202009A0 (en) 2010-06-16
BRPI0811956A8 (pt) 2015-09-22
UA97529C2 (ru) 2012-02-27
AU2008309170A1 (en) 2009-04-16
BRPI0811956A2 (pt) 2014-11-11
EP2211837A2 (en) 2010-08-04
PT2211837E (pt) 2014-02-17
ES2445443T3 (es) 2014-03-03
AP3643A (en) 2016-03-16
ZA200908705B (en) 2010-08-25
US20100120918A1 (en) 2010-05-13
CA2697458A1 (en) 2009-04-16
CN101790370A (zh) 2010-07-28
HK1147066A1 (en) 2011-07-29
MX2009013352A (es) 2010-05-21
CA2697458C (en) 2016-02-09
MY151437A (en) 2014-05-30
EA018119B1 (ru) 2013-05-30
KR101517494B1 (ko) 2015-05-04
CO6270203A2 (es) 2011-04-20
JP2014098046A (ja) 2014-05-29
CN101790370B (zh) 2013-06-12
KR20100047840A (ko) 2010-05-10
WO2009047785A3 (en) 2009-07-02
AU2008309170B2 (en) 2013-03-14
WO2009047785A9 (en) 2010-03-11
JP5734479B2 (ja) 2015-06-17
JP2010529110A (ja) 2010-08-26
EA200971099A1 (ru) 2010-06-30
US10702469B2 (en) 2020-07-07
IL202009A (en) 2015-10-29
DK2211837T3 (da) 2014-02-10
JP5535066B2 (ja) 2014-07-02
WO2009047785A2 (en) 2009-04-16
EP2211837B1 (en) 2013-11-13
CU23999B1 (es) 2014-06-27

Similar Documents

Publication Publication Date Title
CU20090206A7 (es) Solución novedosa no-acuosa tópica de diclofenaco y proceso para su preparación
ECSP12011799A (es) Compuestos de espiropiperidina y uso farmacéutico de los mismos
PE20090512A1 (es) Fenilendiaminas sustituidas como inhibidores de la interaccion entre mdm2 y p53
GT201200164A (es) "nuevos compuestos de espiropiperidina"
AR068369A1 (es) Sal de xinafoato de n4-[(2,2-difluor-4h-benzo[1,4]oxazin-3-on)-6-il]-5-fluor-n2-[3-(metilaminocarbonilmetilenoxi)-fenil]2,4-pirimidindiamina"
CL2008002076A1 (es) Compuestos derivados de ariloxazoles sustituidos; procedimiento de preparacion de dichos compuestos; composicion farmaceutica que los comprende; y su uso para tratar diabetes, sindrome metabolico, dislipidemias, entre otras enfermedades.
BRPI0721905B8 (pt) composto inibidor de proteassoma, sua composição farmacêutica e seu uso
BRPI0712631B8 (pt) compostos, processos para a preparação de um composto, composição farmacêutica, uso de um composto e combinações
CO6620055A2 (es) Ciertas amino-pirimidinas, composiciones de las mismas y métodos para el uso de los mismos
CL2009000882A1 (es) Un compuesto n-(4-cloro-3-(piridin-2-il)fenil)-4-(2-hidroxi-2-metilpropilsulfonil)-2-metilbenzamida, inhibidor de la via de señalización hedgehog; composición farmacéutica que comprende a dicho compuesto; y su uso para tratar el cancer.
CL2007001759A1 (es) Compuesto metformina r-(+) lipoato; mezcla que comprende metformina y acido r-(+) lipoico; composicion farmaceutica que comprende el compuesto; metodo para preparar el compuesto; kit; y uso para tratar la diabetes.
EA201000814A1 (ru) 5-[(3,3,3-трифтор-2-гидрокси-1-арилпропил)амино]-1h-хинолин-2-оны, способ их получения и их применение в качестве противовоспалительных средств
EA201001196A1 (ru) Соединения 4-пиридинона и их применение для лечения рака
MY158428A (en) Topical composition for the treatment of actinic keratosis
CL2011000341A1 (es) Compuestos derivados de pirrolidinona sustituida, moduladores de la actividad de ar para la inhibicion de ntd; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento de cancer, acne, hirsutismo, entre otras.
EA200900090A1 (ru) Бензиламины, способ их получения и их применение в качестве противовоспалительных средств
CR10206A (es) Acidos4-fenil-tiazol-5-carboxilicos amidas de acidos 4-fenil-tiazol-5-carboxilicos como inhibidores de la plk1
CY1115623T1 (el) Μεθοδος για την συνθεση 7,8-διμεθοξυ-1,3-διϋδρο-2η-3-βενζαζεπιν-2-ονης και εφαρμογη αυτης στη συνθεση της ιβαμπραδινης καθως επισης αλατων προσθηκης αυτης με ενα φαρμακευτικως αποδεκτο οξυ
CL2007002919A1 (es) Compuestos derivados de pirido[2,3-b]indol, inhibidores de quinasa; procedimiento de preparacion; composicion farmaceutica; y su uso para tratar cancer, entre otras enfermedades.
EA200300450A1 (ru) Фармацевтические растворы соединений модафинила
ECSP077306A (es) Derivados de alquiliden-tetrahidronaftaleno, procedimiento para su preparación y su uso como antiinflamatorios
PA8657801A1 (es) Aminalcoholes triciclicos, procedimientos para su preparacion
AR080025A1 (es) Derivados de 8-aza-biciclo[3,2,1] oct-3-iloxi)-cromen-2-ona, utiles como inhibidores de la recaptacion del neurotransmisor monoamina
EA201100350A1 (ru) Противогрибковые средства
AR063469A1 (es) Formas polimorficas de ácido (3r,5r)-7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroximetilfenilamino)carbonil]-pirrol-1-il]-3, 5-dihidroxi-heptanoico, sal hemicalcio, metodos de preparacion de las mismas, una composicion farmaceutica que las comprende y su uso en el tratamiento de enfermedades

Legal Events

Date Code Title Description
FG Grant of patent